Combination Gefitinib and Methotrexate to Medically Treat Ectopic Pregnancies: A Phase II Open-Label Single-Arm Study of Efficacy.

Trial Profile

Combination Gefitinib and Methotrexate to Medically Treat Ectopic Pregnancies: A Phase II Open-Label Single-Arm Study of Efficacy.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Gefitinib (Primary) ; Methotrexate
  • Indications Ectopic pregnancy
  • Focus Therapeutic Use
  • Acronyms GEMII-1
  • Most Recent Events

    • 09 Apr 2012 Actual initiation date (23 Feb 2012 ) added as reported by Australian New Zealand Clinical Trials Registry.
    • 29 Nov 2011 New source identified and integrated (EudraCT).
    • 14 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top